Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...
Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...
Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.
Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...
Everyday Health on MSN
Herpes treatment: Home remedies and complementary therapies
Learn what scientific research and experts say about the evidence for common home remedies for herpes, including honey, lemon balm, and petroleum jelly.
WOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...
February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...
Unverified claims in the newly released Epstein files have sparked online speculation about an STD allegedly linked to Bill Gates. However, experts stress these allegations are based on secondary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results